News
Second Genome Appoints Karim Dabbagh, Ph.D., as Chief Executive Officer
September 26, 2018, South San Francisco, CA
Second Genome Appoints Anupama S. Hoey as Chief Business Officer
July 23, 2018, South San Francisco, CA
Second Genome Presents Clinical and Preclinical Data Supporting Development of Its P2X7 Inhibitor, SGM-1019, in NASH at the EASL International Liver Congress 2018
April 9, 2018, South San Francisco, CA